Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Certain DNA variants can predict straight hair in Europeans but are not highly specific.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

Androgens can both increase body hair and cause scalp hair loss.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Androgen use may increase the risk of stroke, but more research is needed.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Effective PCOS treatments require targeting specific signaling pathways.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.